Compare ARK Genomic Revolution ETF (ARKG) vs Gogoro Inc (GGR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Gogoro Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Gogoro Inc trades at $3.85 (market cap $77.28M). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Gogoro Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | GGR | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $7.89 |
52-Week Low | $23.09 | $2.74 |
Market Cap | — | $77.28M |
Enterprise Value | — | $379.73M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
GGR trades at $3.85, up 1.72% today, but faces significant fundamental challenges with a net loss of $79.97 million in 2025 and negative profit margins. Technical indicators show a bearish trend with mixed signals from oscillators. The company's cash flow remains negative despite operational improvements, while analyst consensus remains neutral with 100% hold ratings.
The outlook remains cautious as GGR struggles with profitability despite revenue stability. Investment opportunity exists in the company's low valuation multiples and battery-swapping technology growth, but risks include persistent losses, negative cash flow, and execution challenges in competitive sustainable mobility markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Gogoro Inc
Gogoro is a global technology leader in battery-swapping ecosystems for electric two-wheelers. It provides smart, sustainable urban mobility solutions and manages an extensive network of battery stations.
Read more on GGR →
